ArticleCancer immunology, immunotherapy : CII2022

Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer.

Hong Kyu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.